Schneider-Stock R.; Diab-Assef M.; Rohrbeck A.; Foltzer-Jourdainne C.; Boltze C.; Hartig R.; Schonfeld P.; Roessner A.; Gali-Muhtasib H.
(BETHESDA9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA, 2005)
Methyltransferase inhibitors commonly used in clinical trials promote tumor cell death, but their detailed cytotoxic action is not yet fully understood. A deeper knowledge about their apotosis-inducing mechanisms and their ...